The prostate-specific antigen density, transversal diameter of the prostate, and other variables were used to establish the decision tree model (the variable with maximum gain was selected as the split variable; other hyperparameters used the default settings) to differentiate prostate cancer from benign prostatic hyperplasia [33], achieving a precision of 0.86. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.